Sorrento Provides Manufacturing Support for COVID-19 Treatment; What’s Next?

Sorrento Provides Manufacturing Support for COVID-19 Treatment; What’s Next?

The battle against COVID-19 is well underway, and now’s the time to send in the big guns. Sorrento Therapeutics (SRNE) is on it, offering both active and passive immunization strategies. As a result, it has received positive investor attention, as demonstrated by its 35% one-month gain.As part of these efforts, the healthcare name, which develops therapies to reduce the malignancy of life-threatening tumors, improves the safety of current treatments and brings solutions to make living with cancer more tolerable, partnered with Celularity. Celularity is a privately-held cell therapeutics company that specializes in transformative allogeneic cellular therapies developed from the postpartum human placenta.Serving as a welcome piece of good news, on April 2, it was revealed that the FDA approved Celularity's Investigational New Drug (IND) application for the use of CYNK-001, its natural killer (NK) cell-based immunotherapy candidate to treat critically and severely ill patients with COVID-19. This means that Celularity can...

VIX futures point to coronavirus worries for months to come

Investors are betting on stocks to remain volatile well into the year, suggesting that many expect the long-term economic and public health impact of the pandemic caused by the novel coronavirus to continue roiling markets despite a recent rally. The Cboe Volatility Index, known as Wall Street's fear gauge, recently traded at 43.36 on Wednesday from a record closing high of 82.69 on Mar. 16. Prices for near-term VIX futures, which reflect expectations of volatility in coming months, have dropped as well in the past two weeks....

Fauci Sees Possible Turnaround; N.Y. Deaths Jump: Virus Update

(Bloomberg) -- Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, said the start of a turnaround in the fight against the virus could come after this week, as President Donald Trump’s top health advisers develop medical criteria for reopening the U.S. economy.The U.K. and Belgium had their deadliest day of the outbreak so far, and Spain reported fatalities and new cases rising to the highest in four days. U.K. Prime Minister Boris Johnson is stable and responding to treatment at a London hospital.U.S. Democrats are seeking at least $500 billion in the next stimulus bill, and Hong Kong announced a fresh package valued at about $18 billion. European Union finance ministers failed to agree on a $543 billion recovery plan for the bloc.The World Health Organization cautioned countries against lowering their guards.Key Developments:Global cases top 1.5 million; deaths pass 83,500: Johns HopkinsTrump team prepares plans to...

Staggering Loss of Oil Demand Raises Pressure on OPEC+ to Cut Output

(Bloomberg) -- Global oil demand is plummeting faster than anyone predicted -- with U.S. drivers consuming less gasoline last week than any time in 50 years -- heightening pressure on the world’s biggest producers to cut supply.Yet, with less than 24 hours before an emergency meeting of the OPEC+ alliance on Thursday, Russia and Saudi Arabia still haven’t reached a final deal to cut production, with many details still up in the air, according to people familiar with the negotiations.As the group faces pressure from U.S. President Donald Trump to clinch a 10% cut in global oil supply and resuscitate a market fresh off its worst quarter in history, many fear the cut may not be enough to offset unparalleled demand losses. The stakes could not be higher: What happens Thursday could bend the fortunes of energy players across the globe, from Big Oil and U.S. shale companies, to petro-states such...